ABSTRACT… To analyze the antioxidant activity of Resveratrol and Ascorbic Acid against hydrogen peroxide (an oxidant) mediated cell injury of human trabecular meshwork cells. Study Design: Experimental study. Setting: Molecular Biology Laboratory at Medical Research Centre, Liaquat University of Medical & Health Sciences, Jamshoro. Period: Six months. (21-09-2016 to 20-03-2017). Materials and Methods: Human Trabecular Meshwork cells were purchased from ScienCell Research Laboratories, USA. TM cell metabolism, TM cell viability and Reactive oxygen species were detected by standard methods in co-and pre-treated TM cells. Results: A significant reduction in TM cell metabolism was observed approximating 61% at 1.0 mM H 2 O 2 compared to Ascorbate -99% and Resveratrol 99% (p=0.0001). Resveratrol was more effective than Ascorbate even at 4.0 mM H 2 O 2 , the TM cell activity was noted 76%. Compared to H 2 O 2 -treated TM cells, resveratrol improved mitochondrial function upto 4.0 mM H 2 O 2 (76%). Compared to co-treatment, the pretreatment shows similar results except at 4.0 mM H 2 O 2 . At 4.0 mM H 2 O 2 the pre-treat TM cell metabolic activity was found as 11%, 31% and 47% compared to co-treat as 9%, 31% and 76% in controls, ascorbate and resveratrol groups respectively (p<0.05). Resveratrol shows significant decrease in viability was seen in controls compared to Ascorbate and Resveratrol groups. Cell viability showed statistically significant differences at 2.0 and 4.0 mM H 2 O 2 compared to controls (P=0.0001). For reactive oxygen species (ROS), cells were incubated and with Ascorbate and Resveratrol for 24 hours and TM cells were treated with 0.0mM, 0.5 mM, 1.0 mM, 2.0mM and 4.0mM H 2 O 2 . Significant decrease in ROS was noted by Resveratrol compared to Ascorbate. Conclusions: Resveratrol and Ascorbate may prove useful in preventing and delaying the glaucoma, and timely institution of these anti -oxidants may help maintain trabecular meshwork functions and prevent visual loss.
INTRODUCTION
Pathogenesis of primary open angle glaucoma (POAG) is vague and not elucidated clearly. The previous research work shows the reactive oxygen species (ROS) play major role. The ROS mediated apoptosis of trabecular meshwork (TM) cells has been proposed as one of underlying mechanism in POAG pathogenesis. 1 Physiological impairment of TM cells retards the functioning of these cells, resulting in elevated intraocular pressure (IOP) and glaucoma. A progressive loss of TM cells occurs in patients of glaucoma that is caused by ROS over a long time period. ROS are capable of damaging the TM cells, reducing their physiological role in aqueous humor flow thereby altering the intraocular pressure. 2 Oxidative stress plays major role in the development of glaucoma. ROS damage the TM cells, decrease the nitric oxide, alter the vascular endothelial cell functions and nerve ganglion cell death. 3 Previous research proved that a decrease in anti-oxidant mechanisms of TM cells progresses the POAG. 4 A previous study showed short term exposure of TM cells to sub-lethal doses of hydrogen peroxide (H 2 O 2 ) damages the anatomical integrity of these cells. Adhesion of TM cells to growth matrix was decreased that compromises the tissue integrity and impairs the aqueous humor outflow. 5 While long term H 2 O 2 exposure of cultured TM cells show increased expression of inflammatory markers. 6 enhances the oxidative damage of nuclear and mitochondrial DNA of cultured TM cells from glaucoma patients has been reported by previous studies. 6 This shows the role of oxidative injury in the pathogenesis of glaucoma. A previous study reported the resveratrol plays anti oxidative role against the ROS. Resveratrol is a phenolic compound which exerts anti oxidative, anti-angiogenic, anti-cancer, anti-inflammatory and vasodilator activities. Beneficial effects of resveratrol have been proved in diabetic retinopathy, macular degeneration, cataract and glaucoma. 6 Ascorbic acid is a proved anti-oxidant vitamin. 7 National health survey 2003 reported prevalence of 2.7% blindness among Pakistanis which was surprisingly high in glaucoma patients. 8 The present study was conducted to determine antioxidant and anti-glaucoma activity of resveratrol and ascorbic acid against hydrogen peroxide induced oxidative injury in cultured trabecular meshwork cells.
METHODOLOGY
The present experimental study was conducted at Molecular Biology laboratory, Medical Research Centre, Liaquat University of Medical & Health Sciences, Jamshoro. Human Trabecular Meshwork cells (HTMC) isolated from the Juxtacanalicular and corneo-scleral regions of human eye along with culture media and reagents used in this study were purchased from The ScienCell Laboratories, USA . The vial purchased contained >5 x 10 5 cells in 1 ml volume and was delivered in dry ice, once received the cells were immediately transferred to liquid nitrogen and were kept their until required for experiments. Before culture of the cells, T-75 flasks were prepared with poly-Llysine-coating by adding 10 ml of sterile water to T-75 flask and then adding 15 μl of poly-L-lysine stock solution (10 mg/ml). The flasks were left in 37 o C incubator overnight. Complete medium was prepared under sterile conditions. The poly-L-lysine-coated vessels were rinsed twice with sterile water and then 15 ml of complete medium was added. Once flasks became ready, the frozen vial was placed in a 37 o C water bath and then was rotated gently until the contents thawed completely. The vial was then wiped with 70% ethanol and transferred to sterile field. The cells were re-suspended in poly-L-lysine-coated culture vessel and the vessel was kept in 37 0 C incubator for 24 hours. After 24 hours the culture medium was replaced with fresh culture medium. Culture medium was changed every three days thereafter, until the culture was approximately 70% confluent. Once the culture reached 70% confluency, medium was changed every other day until the confluence reached approximately 90%.
Once cultures reached 90% confluence, subculture was started by rinsing the cells with DPBS (Ca++ -and Mg++ -free). Then 8 ml of DPBS and 2 ml of T/E solution was added into flask. The flask was gently rocked to ensure complete coverage of cells by T/E solution. The flask was then incubated in a 37oC incubator for 2 minutes or until cells completely round up. Change in cell morphology was monitored under light microscope. Use a microscope to monitor the change in cell morphology. During incubation, a 50 ml conical centrifuge tube was prepared with 5 ml of fetal bovine serum. The T/E solution was transferred from the flask to the 50 ml centrifuge tube, after making sure that all the residual cells were collected in 50 ml tube, the tube was centrifuged at 1000 rmp for 5 minutes and cells were resuspended in culture medium. Cells were plated in new poly-L-lysine coated culture flasks with 5x10 6 cells per ml. Figure-1 ). Compared to co-treatment, the pre treatment shows similar results except at 4.0 mM H 2 O 2 . At 4.0 mM H 2 O 2 the pre-treat TM cell metabolic activity was found as 11%, 31% and 47% compared to co-treat as 9%, 31% and 76% in controls, ascorbate and resveratrol groups respectively (p<0.05) ( Table-II and Figure-2 ).
Resveratrol shows significant decrease in viability was seen in controls compared to Ascorbate and Resveratrol groups. Cell viability showed statistically significant differences at 2.0 and 4.0 mM H 2 O 2 compared to controls (P=0.0001) (Table-III and Figure-3 
DISCUSSION
Previous research showed anti-oxidative and anti-inflammatory effects of phytochemicals in glaucoma. 9 The present study analyzed the anti-oxidant and ROS scavenging activity of Resveratrol and ascorbic acid in cultured TM cells.
Cardio-protective, neuroprotective, antiaging effects and chemotherapeutic effects of Resveratrol have been reported. In present study, the Resveratrol showed more promising results as compared to ascorbic acid in determining the TM cell metabolism, TM cell viability and preventive effects on ROS. These findings corroborate with previous reports. 11 In controls, the TM cell metabolism was decreased by 61% compared to 99% Ascorbate and Resveratrol at 1.0 mM H 2 O 2 concentration (p=0.0001). Resveratrol protected TM cell metabolism excellently at 1mM concentration on co-incubation. Mitochondrial function was retained by 76% at 4.0 mM H 2 O 2 concentration by the co-treatment of Resveratrol (Table-I ). Previous data also support the observations of this study related to protective effects of antioxidants in prevention of TM cell damage. 12, 13 Co-and pre-treatment with Resveratrol showed equivalent TM cell metabolism at 4.0 mM H 2 O 2 . Coand pre-treated TM cells metabolism was noted as 9%, 31% and 76% & 11%, 31% and 47% in controls, Ascorbate and Resveratrol respectively (p<0.05). Our findings of resveratrol are consistent with previous studies. In a study conducted on cancer lines, showed the antioxidant properties of resveratrol when the cells were cultured in high glucose and oxygen, which shows the ability of this drug to prevent the ROS induced cell injury 14 , also its positive effects on mitochondrial function , Similar findings were also noted in other studies 17, 18 These results prove the efficacy of Resveratrol and Ascorbate as antioxidants. As ROS play pivotal role in POAG, and anti ROS activity of Resveratrol and Ascorbate may be exploited for its prevention and treatment. 19, 20 A previous study reported decreased adhesion of TM cells to matrix when exposed to sub lethal H 2 O 2 (1 mM). Hence it is postulated that the anti-ROS potential of Resveratrol and Ascorbate may help in prevention of glaucoma. The findings of present study are supported by another previous study that treated the cultured TM cells with sub-lethal H 2 O 2 (0.2 mM) doses. This previous study reported the inflammatory markers were increased in the trabecular meshwork. 21, 22 CONCLUSION From the evidence based findings of present study supported by literature review, it is concluded that the Resveratrol and Ascorbate may prove useful in preventing and delaying the process of glaucoma, and timely institution of these antioxidants may help maintain trabecular meshwork functions and prevent permanent visual loss . 
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